Breaking News Instant updates and real-time market news.

MRUS

Merus

$28.50

-1.48 (-4.94%)

, INCY

Incyte

$148.52

0.56 (0.38%)

05:36
03/21/17
03/21
05:36
03/21/17
05:36

Merus downgraded to Neutral from Buy at Citi

Citi analyst Yigal Nochomovitz downgraded Merus (MRUS) to Neutral saying that while the company's fundamentals continue to look "solid," the stock is fairy valued after rallying 50% following the Incyte (INCY) deal. The analyst raised his price target for the shares to $31 from $26.

MRUS

Merus

$28.50

-1.48 (-4.94%)

INCY

Incyte

$148.52

0.56 (0.38%)

  • 01

    Apr

  • 02

    Apr

  • 19

    Apr

MRUS Merus
$28.50

-1.48 (-4.94%)

12/21/16
JEFF
12/21/16
NO CHANGE
Target $29
JEFF
Buy
Jefferies ups Merus target to $29 after Incyte collaboration
Jefferies analyst Brian Abrahams views today's announced bispecific collaboration between Merus (MRUS) and Incyte (INCY) as a win for Merus. The deal provides "capital flexibility and strong validation" of the company's platform, while enabling maintenance of full rights to its clinical programs, Abrahams tells investors in a research note. He raised his price target for Merus shares to $29 from $21 and keeps a Buy rating on the name. The stock is up 45%, or $6.30, to $20.45 in midday trading.
12/22/16
SBSH
12/22/16
UPGRADE
Target $26
SBSH
Buy
Merus upgraded to Buy from Neutral at Citi
Citi analyst Yigal Nochomovitz upgraded Merus (MRUS) to Buy saying the Incyte (INCY) collaboration deal has "very favorable" terms. The deal with a "high-profile" company coupled with a $200M upfront payment "should meaningfully increase Street visibility," Nochomovitz tells investors in a research note. He raised his price target for Merus shares to $26 from $19. The stock closed yesterday up 43% to $20.22.
12/22/16
12/22/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Micron (MU) was upgraded to Buy from Hold at Cross Research, to Buy from Underperform at Needham, and to Buy from Hold at Summit Redstone. 2. Sunoco (SUN) upgraded to Outperform from Market Perform at FBR Capital with analyst Robert Balsamo saying the credit facility amendments announced reduce the need for a distribution cut. The analyst has a $32 price target for the shares. 3. National Instruments (NATI) upgraded to Outperform from Neutral at Baird with analyst Richard Eastman saying he sees the potential for accelerating revenue growth over the next few years combined with more determined focus to deliver operating leverage. 4. Merus (MRUS) upgraded to Buy from Neutral at Citi with analyst Yigal Nochomovitz saying the Incyte (INCY) collaboration deal has "very favorable" terms. 5. Sucampo (SCMP) upgraded to Buy from Neutral at Mizuho with the firm citing the sell-off in shares post the $260M convertible raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/28/16
JEFF
12/28/16
NO CHANGE
Target $29
JEFF
Buy
Merus still undervalued despite yesterday's rally, says Jefferies
Jefferies analyst Brian Abrahams says he continues to believe shares of Merus (MRUS) are undervalued. The stock rose 5% yesterday to $20.91. Seattle Genetics' (SGEN) toxicity roadblock highlights the unmet need for new mechanisms, but also the challenges in acute myeloid leukemia, Abrahams tells investors in a research note. Merus' MCLA-117 has looked safe thus far and has a differentiated profile, the analyst contends. He keeps a Buy rating on the shares with a $29 price target.
INCY Incyte
$148.52

0.56 (0.38%)

01/31/17
RHCO
01/31/17
NO CHANGE
RHCO
Incyte price target raised to $140 from $115 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Incyte (INCY), citing "increased pipeline & technology value" as data releases and PDUFA dates approach. Additionally, the analyst is upbeat on the company's global collaboration deal with Calithera (CALA), saying that the deal expands Incyte's "reach into the (immuno-oncology) space." The analyst reiterates a Buy rating on Incyte.
03/01/17
NOMU
03/01/17
INITIATION
Target $148
NOMU
Buy
Incyte initiated with a Buy at Nomura
Nomura initiated Incyte with a Buy and a $148 price target.
03/08/17
UBSW
03/08/17
INITIATION
Target $140
UBSW
Neutral
Incyte initiated with a Neutral at UBS
UBS analyst Carter Gould initiated Incyte with a Neutral and a $140 price target.
03/13/17
FBCO
03/13/17
NO CHANGE
Target $174
FBCO
Outperform
Incyte price target raised to $174 from $136 at Credit Suisse
Credit Suisse analyst Kennen MacKay raised his price target for Incyte (INCY) to $174 upon shifting to an M&A discounted cash flow net present value methodology. Incyte rallied late in the day on Friday amid speculation of a takeover by Gilead Sciences (GILD). Incyte could provide an attractive entry into immuno-oncology for an acquirer, MacKay tells investors in a research note. The company's epacadostat could be a "scarce immuno-oncology backbone blockbuster," the analyst contends. He anticipates "significant interest" in Incyte for this reason. MacKay keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

CIT

CIT Group

$48.74

-0.16 (-0.33%)

10:38
07/25/17
07/25
10:38
07/25/17
10:38
Recommendations
CIT Group analyst commentary  »

CIT Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SRPT

Sarepta

$43.95

0.54 (1.24%)

, BIIB

Biogen

$284.70

1.78 (0.63%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Periodicals
STAT's Feuerstein puts Sarepta on list of potential targets for Biogen 

Reference Link

SRPT

Sarepta

$43.95

0.54 (1.24%)

BIIB

Biogen

$284.70

1.78 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 25

    Jul

GM

General Motors

$36.10

0.28 (0.78%)

10:35
07/25/17
07/25
10:35
07/25/17
10:35
Hot Stocks
General Motors expects Q3 to be weakest quarter of the year 

Sees recovery in Q4.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue plans to update the market at year-end with its fleet review »

Comments provided during…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

JBLU

JetBlue

$22.76

-0.69 (-2.94%)

10:34
07/25/17
07/25
10:34
07/25/17
10:34
Hot Stocks
JetBlue achieved $45M of $250M-$300M cost savings expected by FY20 »

JetBlue sees FY17-FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 10

    Aug

LLY

Eli Lilly

$82.04

-2.6978 (-3.18%)

10:33
07/25/17
07/25
10:33
07/25/17
10:33
Hot Stocks
Eli Lilly sees drug pricing executive order in second half of 2017 »

Eli Lilly CEO David Ricks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

POWI

Power Integrations

$81.75

0.2 (0.25%)

, AAPL

Apple

$152.09

1.82 (1.21%)

10:32
07/25/17
07/25
10:32
07/25/17
10:32
Hot Stocks
Power Integrations cut to hold after Apple speculation fuels run-up »

The shares of Power…

POWI

Power Integrations

$81.75

0.2 (0.25%)

AAPL

Apple

$152.09

1.82 (1.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 01

    Aug

TSLA

Tesla

$342.52

14.12 (4.30%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Hot Stocks
Tesla Model S 'tops Consumer Reports' ratings' after adding AEB, CR says »

After updating its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

APRN

Blue Apron

$7.49

0.08 (1.08%)

, BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

APRN

Blue Apron

$7.49

0.08 (1.08%)

BUFF

Blue Buffalo Pet Products

$23.11

-0.01 (-0.04%)

ELF

e.l.f. Beauty

$26.61

1.21 (4.76%)

GWW

Grainger

$167.84

0.96 (0.58%)

WMC

Western Asset Mortgage

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Aug

  • 10

    Aug

  • 17

    Oct

  • 24

    Jan

UA

Under Armour

$18.21

-0.0485 (-0.27%)

, UAA

Under Armour

$20.29

0.02 (0.10%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

UA

Under Armour

$18.21

-0.0485 (-0.27%)

UAA

Under Armour

$20.29

0.02 (0.10%)

SNAP

Snap

$13.73

-0.355 (-2.52%)

CYTX

Cytori Therapeutics

$0.48

-0.6301 (-56.77%)

LULU

lululemon

$62.02

0.08 (0.13%)

POWI

Power Integrations

$81.75

0.2 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 10

    Aug

  • 13

    Sep

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

, BIG

Big Lots

$49.66

2.1 (4.42%)

10:31
07/25/17
07/25
10:31
07/25/17
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

MDLZ

Mondelez

$43.75

-0.28 (-0.64%)

BIG

Big Lots

$49.66

2.1 (4.42%)

WERN

Werner

$29.20

-0.35 (-1.18%)

TEAM

Atlassian

$36.41

0.66 (1.85%)

DSW

DSW

$17.35

0.87 (5.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 02

    Aug

  • 08

    Aug

  • 21

    Aug

  • 25

    Sep

WBA

Walgreens Boots Alliance

$79.60

0.7 (0.89%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Hot Stocks
Walgreens to bring nearly 500 jobs to Chandler, Arizona »

Walgreens announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

FCX

Freeport McMoRan

$14.38

1.415 (10.92%)

10:30
07/25/17
07/25
10:30
07/25/17
10:30
Options
Freeport McMoran options active after earnings »

Freeport McMoran options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:30
07/25/17
07/25
10:30
07/25/17
10:30
General news
Treasury Action: yields resumed their rise »

Treasury Action: yields…

SVU

Supervalu

$3.56

0.305 (9.38%)

10:28
07/25/17
07/25
10:28
07/25/17
10:28
Hot Stocks
Supervalu says FY18 base adjusted EBITDA view same ex-Unified contibution »

Sees adjusted EBITDA with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GM

General Motors

$35.90

0.0845 (0.24%)

10:27
07/25/17
07/25
10:27
07/25/17
10:27
Hot Stocks
Breaking Hot Stocks news story on General Motors »

GM CFO says 'very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

10:25
07/25/17
07/25
10:25
07/25/17
10:25
General news
U.S. Richmond Fed manufacturing index rose 3 points to 14 in July »

U.S. Richmond Fed…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

, CZR

Caesars

$12.90

0.2 (1.57%)

10:25
07/25/17
07/25
10:25
07/25/17
10:25
Conference/Events
Caesars to host special shareholder meeting »

Special Shareholder…

CACQ

Caesars Acquisition

$20.45

0.3 (1.49%)

CZR

Caesars

$12.90

0.2 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 25

    Jul

  • 03

    Aug

SVU

Supervalu

$3.56

0.31 (9.54%)

, AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

10:24
07/25/17
07/25
10:24
07/25/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Supervalu, Amazon.com, Whole Foods »

Supervalu sees retail…

SVU

Supervalu

$3.56

0.31 (9.54%)

AMZN

Amazon.com

$1,038.95

13.28 (1.29%)

WFM

Whole Foods

$41.67

-0.04 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Jul

FCX

Freeport McMoRan

$14.28

1.315 (10.15%)

10:22
07/25/17
07/25
10:22
07/25/17
10:22
Hot Stocks
Freeport McMoRan sees 2018 consolidated copper sales of 3.85B pounds »

Freeport sees FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GM

General Motors

$35.91

0.09 (0.25%)

10:20
07/25/17
07/25
10:20
07/25/17
10:20
Hot Stocks
GM sees North America EBIT adjusted margins of 10%+ for FY17 »

CEO Mary Barra says Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

RMBS

Rambus

$12.64

0.03 (0.24%)

10:20
07/25/17
07/25
10:20
07/25/17
10:20
Options
Bullish option play in Rambus after earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 29

    Aug

  • 08

    Sep

  • 12

    Sep

10:20
07/25/17
07/25
10:20
07/25/17
10:20
General news
FX Action: The dollar »

FX Action: The dollar…

F

Ford

$11.30

0.0141 (0.12%)

10:19
07/25/17
07/25
10:19
07/25/17
10:19
Conference/Events
Ford to host sales conference call »

Vice President LeNeve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

TSLA

Tesla

$342.52

14.12 (4.30%)

10:19
07/25/17
07/25
10:19
07/25/17
10:19
Hot Stocks
Tesla Model S 'tops Consumer Reports' ratings' after adding AEB, CR says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 08

    Aug

  • 02

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.